Evidence map›Paper›PMID 23636738›Full record

ArticleGenetics2013

Rare variant association testing under low-coverage sequencing.

Oron Navon, Jae Hoon Sul, Buhm Han, Lucia Conde, Paige M Bracci, Jacques Riby, Christine F Skibola, Eleazar Eskin, Eran Halperin

Abstract read
In one paragraph

Article in Genetics, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. A Statistical Approach to Fine Mapping for the Identification of Potential Causal Variants Related to Bone Mineral Density.Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2017
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Copper phenotype in Alzheimer's disease: dissecting the pathway.American journal of neurodegenerative disease · 2013
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Oron NavonMolecular Microbiology and Biotechnology Department, Tel-Aviv University, Tel Aviv 69978, Israel.
Jae Hoon Sul
Buhm Han
Lucia Conde
Paige M Bracci
Jacques Riby
Christine F Skibola
Eleazar Eskin
Eran Halperin

Funding

ULTRASTRUCTURE OF THE INTIMA IN EARLY LESION FORMATIONP01HL030568 · NHLBI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI FOGELMAN, ALAN M · 1985 to 2019
$55.2M
Systems genomics of metabolic syndrome traitsP01HL028481 · NHLBI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI LUSIS, ALDONS JAKE · 1985 to 2019
$50.2M
Substance Abuse & Behavioral Disinhibition: Integrating Genes & EnvironmentU01DA024417 · NIDA · UNIVERSITY OF MINNESOTA · PI IACONO, WILLIAM G. · 2007 to 2010
$10.8M
Molecular Epidemiology of non Hodgkin's LymphomaR01CA087014 · NCI · UNIVERSITY OF CALIFORNIA SAN FRANCISCO · PI HOLLY, ELIZABETH A. · 2001 to 2005
$6.7M
Genetic Susceptibility to Non-Hodgkins LymphomaR01CA104682 · NCI · UNIVERSITY OF CALIFORNIA BERKELEY · PI SKIBOLA, CHRISTINE F. · 2003 to 2012
$2.6M
Resequencing and Functional Studies to Identify Causal Gene Variants of LymphomaR01CA154643 · NCI · UNIVERSITY OF CALIFORNIA BERKELEY · PI ZHANG, JIANQING · 2011 to 2014
$2.4M
Fine-mapping the MHC associations in rheumatoid arthritis from GWAS dataR01AR062886 · NIAMS · BRIGHAM AND WOMEN'S HOSPITAL · PI RAYCHAUDHURI, SOUMYA · 2012 to 2013
$783k
Discovering the Genetic Basis of HypertensionK25HL080079 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI ESKIN, ELEAZAR · 2006 to 2010
$685k
EPIDEMIOLOGY OF NON HODGKINS'S LYMPHOMA DATA ANALYSISR03CA089745 · NCI · UNIVERSITY OF CALIFORNIA SAN FRANCISCO · PI HOLLY, ELIZABETH A. · 2001 to 2002
$148k
EPIDEMIOLOGY OF NON-HODGKIN'S LYMPHOMA &RETROVIRAL TESTR01CA045614 · NCI · UNIVERSITY OF CALIFORNIA SAN FRANCISCO · PI HOLLY, ELIZABETH A. · 1988 to 1992
–
NCI NIH HHS CA104682NCI NIH HHS CA154643NCI NIH HHS CA87014NCI NIH HHS CA89745NCI NIH HHS R01 CA045614NCI NIH HHS R01 CA087014NCI NIH HHS R01 CA104682NCI NIH HHS R01 CA154643NCI NIH HHS R03 CA089745NHLBI NIH HHS K25 HL080079NHLBI NIH HHS K25-HL080079NHLBI NIH HHS P01 HL028481NHLBI NIH HHS P01 HL030568NHLBI NIH HHS P01-HL28481NHLBI NIH HHS P01-HL30568NIAMS NIH HHS 1R01AR062886-01NIAMS NIH HHS R01 AR062886NIDA NIH HHS U01 DA024417NIDA NIH HHS U01-DA024417
6 · The paper itself

Abstract

Deep sequencing technologies enable the study of the effects of rare variants in disease risk. While methods have been developed to increase statistical power for detection of such effects, detecting subtle associations requires studies with hundreds or thousands of individuals, which is prohibitively costly. Recently, low-coverage sequencing has been shown to effectively reduce the cost of genome-wide association studies, using current sequencing technologies. However, current methods for disease association testing on rare variants cannot be applied directly to low-coverage sequencing data, as they require individual genotype data, which may not be called correctly due to low-coverage and inherent sequencing errors. In this article, we propose two novel methods for detecting association of rare variants with disease risk, using low coverage, error-prone sequencing. We show by simulation that our methods outperform previous methods under both low- and high-coverage sequencing and under different disease architectures. We use real data and simulation studies to demonstrate that to maximize the power to detect associations for a fixed budget, it is desirable to include more samples while lowering coverage and to perform an analysis using our suggested methods.

Indexed as

Gene FrequencyHigh-Throughput Nucleotide SequencingModels, GeneticGenetic Predisposition to DiseaseGenome-Wide Association StudyGenotypeHumansPolymorphism, Single NucleotideSequence Analysis, DNAassociation testlow-coverage sequencingpoolingrare variantssequencing

Identifiers

PMID23636738
PMCPMC3697979

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.